Negar Ashouri, M.D.
Office and Contact Information
1201 W La Veta
Orange, CA 92868
phone: (714) 509-8403
fax: (714) 509-4014
map & directions
Physician / Researcher BioNegar Ashouri, M.D. is board certified in pediatrics and pediatric infectious diseases. She completed medical school At St. George's University School of Medicine in Grenada, West Indies. Dr. Ashouri completed her residency training at Children's Hospital of Orange County, followed by a year as Chief Resident. After doing her fellowship in pediatric infectious diseases at Children’s Hospital of Los Angeles, she returned to CHOC where she is currently a pediatric infectious disease specialist with clinical interests in Kawasaki disease and neonatal infections.
ResearchCurrently, Dr. Ashouri is involved in a number of research projects dealing with bloodstream infections and drug trials. She is also part of the Collaborative Antiviral Study Group. To further Dr. Ashouri’s research, she maintains an ongoing database of blood cultures and can frequently be found looking back through patient data and charts as she investigates how vaccines impacts infections and specific risk factors for high-risk groups.
Because of Dr. Ashouri’s passion for treating and researching pediatric infections diseases she has published widely on the subject and has been invited to speak at numerous conferences on her findings.
- Medical School
St George's University School of Medicine, Grenada, West Indies
- Pediatrics Residency
Children's Hospital of Orange County, CA
- Pediatric Infectious Diseases Fellowship
Children's Hospital of Los Angeles, CA
- Pediatric Infectious Disease
|More than 80 CHOC Children's Doctors Named "Physicians of Excellence"
January 03, 2012
More than 80 CHOC Children's physicians, including specialists and pediatricians, are named "Physicians of Excellence" by the Orange County Medical Association....
Arrieta AC, Shea K, Dhar V, Cleary JP, Kukreja S, Morris M, Vargas-Shiraishi OM, Ashouri N, Singh J. Once-weekly liposomal amphotericin B as Candida prophylaxis in very low birth weight premature infants: a prospective, randomized, open-label, placebo-controlled pilot study. Clin Ther. 2010 Feb;32(2):265-71.
Chuang M, Singh J, Ashouri N, Katz M, Arrieta A. Listeria Meningitis after Influximab Therapy for Ulcerative Colitis. J Pediatr Gastroenterol Nutr. 2010 Mar;50(3):337-9.
Ashouri N, Takahashi M, Dorey F, and Mason W. Risk Factors for Non-Response to Therapy in Kawasaki Disease. J Pediatr. 2008 Sep;153(3):365-8.
Bennetto-Hood C, Aldrovandi GM, King JR, Woodman K, Ashouri N, and Acosta EP. Persistence of Nevirapine in Breastmilk After Discontinuation of Treatment. CID, 2007:45; 391-394.
Ashouri N, Singh J, Arrieta A. Micafungin in Pediatrics: when one size does not fit all. Expert Opin. on Drug Metab. & Toxicol. 2008 April; 4 (4): 463-469
Ashouri N, Mason W. MRSA in Los Angeles, an info sheet for Clinicians. Pediatric News, Vol 47, No.7, Summer 2006.
Amebic Encephalitis Caused by Balamuthia madrillaris: Report of Four Cases. Bakardjiev A. Azimi P, Ashouri N et al. Pediatric Infectious Disease Journal: 2003;22:447-452
Urinary Tract Infections in Neonates: How Aggressive a Workup and Therapy? Ashouri N. Butler J et al Infections in Medicine 2003:20:98-102
The Effects of Triamcinalone on the Functional Recovery of the Rat Sciatic Nerve, Ashouri N. UCI’S Journal of Undergraduate Research
Arrieta AC, Vargas-Shiraishi O, Ashouri N, Adler F, Singh J. Streptococcus Pneumoiae Blood Stream Infections (BSI) in Hospitalized Children after Broad Utilizacion of Heptavalente Pneumococcal Conjugate Vaccine (PCV-7). Accepted for poster presentation for the 2009 European Society for Paediatric Infectious Diseases (ESPID), Brussels, Belgium, June 09-13, 2009.
Ashouri N, Singh J, Vargas-Shiraishi O, Arrieta A. Clinical and Microbiological Factors Affecting Outcome in Hospitalized Children with Candidemia. Accepted for poster presentation for the 27th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Brussels, Belgium, June 09-13, 2009
Ashouri N, Singh J, Vargas-Shiraishi O, Arrieta A. Identification of Factors Affecting Incidence and Outcome of Candidemia in a Neonatal Intensive Care Unit for Developing Prophylaxis Strategies. Accepted for poster presentation for the 27th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID), Brussels, Belgium, June 09-13, 2009
Arrieta AC, Shea K, Dhar V, Cleary J, Kukreja S, Morris M, Ashouri N, Singh J: Safety and Efficacy of Liposomal Amphotericin B (L-AmB) as a Prophylactic Regimen for the Prevention of Candida Colonization and Systemic Infection in Very Low Birth Weight (VLBW) Premature Infants. Poster presentation at PAS, Honolulu, HI, May 2008.
Arrieta AC, Shea K, Dhar V, Cleary J, Kukreja S, Ashouri N, Singh J: Safety of Liposomal Amphotericin as a Once Weekly Antifungal Prophylactic Regimen in Very Low Birth Weight Premature Infants. Poster Presentation at ECCMID, Barcelona, Spain, April 2008.
Ashouri N, Takahashi M, Mason W. Variation and Risk Factor for Non-response to Treatment in Kawasaki Disease. IX International Kawasaki Disease Symposium. April 10-12, 2008. Taipei, Taiwan.
Singh J, Bendig EA, Vargas-Shiraishi OM, Wronski, SA, Ashouri N, Arrieta, AC Microbiology (Micro) of Community Acquired (CA) Blood Stream Infection (BSI) After Introduction of Streptococcus pneumoniae (SP) Conjugated vaccine and its impact on the reliability of traditional diagnostic criteria. Poster Presentation. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 2007. Chicago IL
Ashouri N, Mason W, Apparent Increase in Kawasaki Disease (KD) Cases Refractory to Intravenous Immunoglobulin 2007 Pediatric Academic Societies Meeting, May 5-8, Toronto, Canada.
Ashouri N, Ross L, Mason W. Voriconazole Use at CHLA. 43rd Annual IDSA, October 6-9 2005. San Francisco, California.
Arrieta AC, Shea K, Dhar V, Cleary J, Kukreja S, Morris M, Ashouri N, Singh J Safety and Efficacy of Liposomal Amphotericin B (L-AmB) as a Prophylactic Regimen for the Prevention of Candida Colonization and Systemic Infection in Very Low Birth Weight (VLBW) Premature Infants. Poster Presentation. Pediatric Academic Societies and Asian Society for Pediatric Research 2008 Joint Meeting. May 2008. Honolulu, Hawaii
Ashouri N, Vargas-Shiraishi O, Singh J, Arrieta A. Treatment (tx) of Pediatric Acute Hematogenous Skeletal Infections (ASHI): How aggressive should we be? Poster presentation. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). September 14-17, 2003 Chicago Illinois
Ashouri N, Butler J, Vargas-Shiraishi OM, Singh J, and Arrieta AC. New Approach to the Management of Urinary Tract Infection in Neonates. A Challenge to Current Dogmas. Poster Presentation. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco California, September 1999. Accepted for publication Infections in Medicine.
Ashouri, N. The Effects of Triamcinalone on the Functional Recovery of the Rat Sciatic Nerve
9th Annual Excellence in Research Symposium, UCI